Clinically nonfunctioning pituitary tumors are monoclonal in origin

J Clin Invest. 1990 Jul;86(1):336-40. doi: 10.1172/JCI114705.

Abstract

Clinically nonfunctioning pituitary adenomas are benign neoplasms comprising approximately 25-30% of pituitary tumors. Little is known about the pathogenesis of pituitary neoplasia. Clonal analysis allows one to make the important distinction between a polyclonal proliferation in response to a stimulatory factor versus a monoclonal expansion of a genetically aberrant cell. We investigated the clonal origin of pituitary tumors using X-linked restriction fragment length polymorphisms at the phosphoglycerate kinase and hypoxanthine phosphoribosyl-transferase genes. Restriction enzymes were used to distinguish maternal and paternal X-chromosomes, and combined with a methylation-sensitive restriction enzyme to analyze allelic X-inactivation patterns in six pituitary adenomas. All six tumors showed a monoclonal pattern of X-inactivation. These data indicate that nonfunctioning pituitary adenomas are unicellular in origin, a result consistent with the hypothesis that this tumor type is due to somatic mutation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenoma / genetics
  • Adenoma / pathology*
  • Adult
  • Blotting, Southern
  • Clone Cells
  • Dosage Compensation, Genetic
  • Humans
  • Hypoxanthine Phosphoribosyltransferase / genetics
  • Methylation
  • Middle Aged
  • Phosphoglycerate Kinase / genetics
  • Pituitary Neoplasms / genetics
  • Pituitary Neoplasms / pathology*
  • Polymorphism, Restriction Fragment Length

Substances

  • Hypoxanthine Phosphoribosyltransferase
  • Phosphoglycerate Kinase